1. Lenalidomide as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathy. (27th April 2016) Authors: Lavin, M.; Brophy, T. M.; Rawley, O.; O'Sullivan, J. M.; Hayden, P. J.; Browne, P. V.; Ryan, K.; O'Connell, N.; O'Donnell, J. S. Journal: Journal of thrombosis and haemostasis Issue: Volume 14:Number 6(2016:Jun.) Page Start: 1200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P957: CARFILZOMIB, LENALIDOMIDE, DEXAMETHASONE FOLLOWED BY A SECOND AUTO-HCT IS AN EFFECTIVE STRATEGY IN FIRST RELAPSE MULTIPLE MYELOMA: A STUDY OF THE CHRONIC MALIGNANCIES WORKING PARTY OF EBMT. (23rd June 2022) Authors: Tilmont, R.; Yakoub-Agha, I.; Eikema, D.-J.; Zinger, N.; Haenel, M.; Schaap, N.; Herrera Arroyo, C.; Schuermans, C.; Bethge, W.; Engelhardt, M.; Kuball, J.; Michieli, M.; Schub, N.; Wilson, K. M. O.; Bourhis, J. H.; Mateos, M. V.; Robin, N.; Jost, E.; Kröger, N.; Moraleda, J. M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 847 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗